{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:14:57Z","timestamp":1789546497521,"version":"build-2803163510"},"reference-count":65,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Research for Patient Benefit"],"award-info":[{"award-number":["Research for Patient Benefit"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,1,18]]},"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The inappropriate use of antipsychotics in people with dementia for behaviour that challenges is associated with an estimated 1800 deaths annually. However, solely focusing on antipsychotics may transfer prescribing to other equally dangerous psychotropics. Little is known about the role of pharmacists in the management of psychotropics used to treat behaviours that challenge. This research aims to determine whether it is feasible to implement and measure the effectiveness of a combined pharmacy\u2013health psychology intervention incorporating a medication review and staff training package to limit the prescription of psychotropics to manage behaviour that challenges in care home residents with dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/analysis<\/jats:title>\n                    <jats:p>6 care homes within the West Midlands will be recruited. People with dementia receiving medication for behaviour that challenges, or their personal consultee, will be approached regarding participation. Medication used to treat behaviour that challenges will be reviewed by the pharmacist, in collaboration with the general practitioner (GP), person with dementia and carer. The behavioural intervention consists of a training package for care home staff and GPs promoting person-centred care and treating behaviours that challenge as an expression of unmet need. The primary outcome measure is the Neuropsychiatric Inventory-Nursing Home version (NPI-NH). Other outcomes include quality of life (EQ-5D and DEMQoL), cognition (sMMSE), health economic (CSRI) and prescribed medication including whether recommendations were implemented. Outcome data will be collected at 6\u2005weeks, and 3 and 6\u2005months. Pretraining and post-training interviews will explore stakeholders\u2019 expectations and experiences of the intervention. Data will be used to estimate the sample size for a definitive study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics\/dissemination<\/jats:title>\n                    <jats:p>The project has received a favourable opinion from the East Midlands REC (15\/EM\/3014). If potential participants lack capacity, a personal consultee will be consulted regarding participation in line with the Mental Capacity Act. Results will be published in peer-reviewed journals and presented at conferences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-010279","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:26:21Z","timestamp":1458779181000},"page":"e010279","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy\u2013health psychology intervention feasibility study"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4152-9704","authenticated-orcid":false,"given":"Ian D","family":"Maidment","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Life and Health Sciences, Medicines and Devices in Ageing Cluster Lead, Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Psychology, School of Life and Health Sciences, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Killick","sequence":"additional","affiliation":[{"name":"School of Life and Health Sciences, Aston University, Birmingham, UK"},{"name":"Social Dimensions of Health Institute, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Damery","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hilton","sequence":"additional","affiliation":[{"name":"Faculty of Health and Social Care, University of Hull, Hull, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Wilcock","sequence":"additional","affiliation":[{"name":"Research Department of Primary Care & Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Barnes","sequence":"additional","affiliation":[{"name":"Pharmacy, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Brown","sequence":"additional","affiliation":[{"name":"Pharmacy, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gillespie","sequence":"additional","affiliation":[{"name":"Department of Clinical Healthcare, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Clinical Psychiatry, Medical School, University of East Anglia, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Barton","sequence":"additional","affiliation":[{"name":"Norwich Medical School and Norwich Clinical Trials Unit, University of East Anglia, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Iliffe","sequence":"additional","affiliation":[{"name":"Research Department of Primary Care & Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Seare","sequence":"additional","affiliation":[{"name":"Aston Health Research and Innovation Cluster, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"2025121221402118000_6.3.e010279.1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050076"},{"key":"2025121221402118000_6.3.e010279.2","unstructured":"Department of Health. Living well with dementia: a national dementia strategy. London: Stationary Office, 2008. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/168220\/dh_094051.pdf (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7544.741"},{"key":"2025121221402118000_6.3.e010279.4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1176\/ps.48.10.1289","article-title":"The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities","volume":"48","author":"Borson","year":"1997","journal-title":"Psych Ser"},{"key":"2025121221402118000_6.3.e010279.5","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F"},{"key":"2025121221402118000_6.3.e010279.6","unstructured":"Department of Health. The use of antipsychotic medication for people with dementia: time for action living well with dementia: s national dementia strategy. London: Stationary Office, 2009. http:\/\/psychrights.org\/research\/digest\/nlps\/BanerjeeReportOnGeriatricNeurolepticUse.pdf (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.7","doi-asserted-by":"publisher","DOI":"10.1002\/gps.3769"},{"key":"2025121221402118000_6.3.e010279.8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.1.59"},{"key":"2025121221402118000_6.3.e010279.9","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G293"},{"key":"2025121221402118000_6.3.e010279.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.02009.x"},{"key":"2025121221402118000_6.3.e010279.11","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.106"},{"key":"2025121221402118000_6.3.e010279.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.8.781"},{"key":"2025121221402118000_6.3.e010279.13","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afg081"},{"key":"2025121221402118000_6.3.e010279.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.03.044"},{"key":"2025121221402118000_6.3.e010279.15","unstructured":"Taylor D , Paton C , Kapur S . The Maudsley prescribing guidelines in psychiatry. 12th Revised edn. John Wiley and Sons Ltd, 2014."},{"key":"2025121221402118000_6.3.e010279.16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-7-201004060-00006"},{"key":"2025121221402118000_6.3.e010279.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2025121221402118000_6.3.e010279.18","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.101406"},{"key":"2025121221402118000_6.3.e010279.19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.regg.2009.10.002","article-title":"Recommendations for the prevention of adverse drug reactions in older adults with dementia","volume":"45","author":"G\u00f3mez-Pav\u00f3n","year":"2010","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"2025121221402118000_6.3.e010279.20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.2.188"},{"key":"2025121221402118000_6.3.e010279.21","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199100630-00002"},{"key":"2025121221402118000_6.3.e010279.22","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1943"},{"key":"2025121221402118000_6.3.e010279.23","unstructured":"Health and Social Care Information Centre. National Dementia and Anti-psychotic Prescribing Audit. 2012. http:\/\/www.hscic.gov.uk\/dementiaaudit (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.24","first-page":"CD007726","article-title":"Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia","volume":"3","author":"Declercq","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121221402118000_6.3.e010279.25","unstructured":"Royal Pharmaceutical Society \/ Dementia Action Alliance \/ Institute for Innovation and Improvement. The Right Prescription: a Call to Action. 2011. http:\/\/www.rpharms.com\/support-pdfs\/the-right-prescription.pdf (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03071.x"},{"key":"2025121221402118000_6.3.e010279.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38338.674583.AE"},{"key":"2025121221402118000_6.3.e010279.28","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp09X473295"},{"key":"2025121221402118000_6.3.e010279.29","first-page":"1","article-title":"Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice","volume":"313","author":"Zermansky","year":"2001","journal-title":"BMJ"},{"key":"2025121221402118000_6.3.e010279.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2009.02617.x"},{"key":"2025121221402118000_6.3.e010279.31","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cml075"},{"key":"2025121221402118000_6.3.e010279.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61091-5"},{"key":"2025121221402118000_6.3.e010279.33","unstructured":"Department of Health. Liberating the NHS. London: Stationary Office, 2010. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/213823\/dh_117794.pdf (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.34","unstructured":"Department of Health. Pharmacy in England\u2014Building on strengths. London: Stationary Office, 2008. https:\/\/www.gov.uk\/government\/publications\/pharmacy-in-england-building-on-strengths-delivering-the-future (accessed 30 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1745-6215-14-13","article-title":"Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial","volume":"14","author":"Whitaker","year":"2013","journal-title":"Trials"},{"key":"2025121221402118000_6.3.e010279.36","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121221402118000_6.3.e010279.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687"},{"key":"2025121221402118000_6.3.e010279.38","unstructured":"DeNDRoN. ENRICH\u2014Enabling Research in Care Homes. 2011. http:\/\/www.dendron.org.uk\/enrich\/ (accessed on 5 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.39","unstructured":"Maidment I , Scott H , Gardiner P . Secondary care clinical pharmacist medication review in care homes: a feasibility study. Health Services Research Conference; Manchester, 2012."},{"key":"2025121221402118000_6.3.e010279.40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-155"},{"key":"2025121221402118000_6.3.e010279.41","unstructured":"Medical Research Council. Developing and evaluating complex interventions: new guidance. 2008. http:\/\/www.mrc.ac.uk\/Utilities\/Documentrecord\/index.htm?d=MRC004871 (accessed 27 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.42","unstructured":"Michie S , Atkins L , West R . The behaviour change wheel: a guide to designing interventions. Silverback Publishing, 2015. http:\/\/www.behaviourchangewheel.com\/ (accessed 15 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2308"},{"key":"2025121221402118000_6.3.e010279.44","unstructured":"npi Test. Neuropsychiatric Inventory (NPI)\u2014setting the standard for Alzheimer's Research. 2012. http:\/\/npitest.net\/npi\/pharmaceutical-and-biotechnology\/why-use-the-npi-in-clinical-trials.html (accessed 3 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.45","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1108"},{"key":"2025121221402118000_6.3.e010279.46","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291706009469"},{"key":"2025121221402118000_6.3.e010279.47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jalz.2007.04.384","article-title":"The development of a new measure of health related quality of life for people with dementia\u2014DEMQoL\u2014use in research and clinical practice","volume":"3","author":"Banerjee","year":"2007","journal-title":"Alzheimers Demen"},{"key":"2025121221402118000_6.3.e010279.48","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2025121221402118000_6.3.e010279.49","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.1.102"},{"key":"2025121221402118000_6.3.e010279.50","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610297004754"},{"key":"2025121221402118000_6.3.e010279.51","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"2025121221402118000_6.3.e010279.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb01992.x"},{"key":"2025121221402118000_6.3.e010279.53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035185"},{"key":"2025121221402118000_6.3.e010279.54","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.613"},{"key":"2025121221402118000_6.3.e010279.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066583"},{"key":"2025121221402118000_6.3.e010279.56","unstructured":"National Institute for Health and Clinical Excellence. NICE Guide to the Methods of Technology Appraisal. 2008. https:\/\/www.nice.org.uk\/ (accessed 20 Aug 2015)."},{"key":"2025121221402118000_6.3.e010279.57","unstructured":"Beecham J , Knapp M . Costing psychiatric interventions. In: Thornicroft G , ed. Measuring Mental Health Needs. 2nd edn. London: Royal College of Psychiatrists, 2001:200\u201324."},{"key":"2025121221402118000_6.3.e010279.58","doi-asserted-by":"crossref","unstructured":"Ritchie J , Spencer L . Qualitative data analysis for applied policy research. In: Bryman A , Burgess R , eds. Analysing qualitative data. London: Routledge, 1993:173\u201394.","DOI":"10.4324\/9780203413081_chapter_9"},{"key":"2025121221402118000_6.3.e010279.59","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025121221402118000_6.3.e010279.60","unstructured":"Curtis L . Unit costs of health and social care 2011. Personal Social Services Research Unit, The University of Kent, 2011."},{"key":"2025121221402118000_6.3.e010279.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.10.016"},{"key":"2025121221402118000_6.3.e010279.62","unstructured":"Department for Constitutional Affairs. Mental Capacity Act 2005. London: Stationary Office, 2005. http:\/\/www.legislation.gov.uk\/ukpga\/2005\/9\/pdfs\/ukpga_20050009_en.pdf (accessed 21 Sep 2015)."},{"key":"2025121221402118000_6.3.e010279.63","unstructured":"Department for Constitutional Affairs. Mental Capacity Act 2005\u2014Code of Practice. Norwich: Stationary Office, 2007."},{"key":"2025121221402118000_6.3.e010279.64","unstructured":"Nind M . Conducing qualitative research with people with learning communication and other disabilities: methodological challenges. ESRC National Centre for Research Methods, 2008. http:\/\/eprints.ncrm.ac.uk\/491\/ (accessed 17 Mar 2015)."},{"key":"2025121221402118000_6.3.e010279.65","unstructured":"National Research Ethics Service. Information sheets and consent forms\u2014guidance for researchers and reviewers. National Research Ethics Service, 2007. http:\/\/www.nres.npsa.nhs.uk\/rec-community\/guidance\/#PIS (accessed 24 Sep 2015)."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-010279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:40:28Z","timestamp":1765604428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-010279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,23]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1136\/bmjopen-2015-010279"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-010279","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}